The impact of interlaboratory differences in cystatin C assay measurement on glomerular filtration rate estimation

Christine A White1, Andrew D Rule, Christine P Collier

  • 1Division of Nephrology, Department of Medicine, Queen’s University, Kingston, Ontario, Canada. cw38@queensu.ca

Insights

Laboratory differences in Cystatin C (CysC) measurements significantly impact estimated glomerular filtration rate (eGFR) calculations. This variability, even with identical assays, necessitates careful interpretation of CysC and eGFR results.

Area of Science:

  • Clinical Chemistry
  • Nephrology
  • Laboratory Medicine

Background:

  • Cystatin C (CysC) is a key biomarker for estimating glomerular filtration rate (GFR).
  • Existing equations for GFR estimation from CysC show performance variability in validation studies.
  • This variability persists even when using the same CysC assay from a single manufacturer.

Purpose of the Study:

  • To investigate discrepancies in CysC measurements and estimated GFR (eGFR) between two laboratories.
  • To evaluate the performance of the Mayo Clinic equation for eGFR using Siemens' nephelometric immunoassay.
  • To assess the predictive accuracy of eGFR for measured GFR.

Main Methods:

  • Ninety-seven split patient samples were analyzed.
  • Samples were processed at the Children's Hospital of Eastern Ontario (CHEO) and the Mayo Clinic.
  • Siemens' nephelometric immunoassay and the Mayo Clinic equation were employed.

Main Results:

  • CHEO CysC measurements were, on average, 0.17 mg/L (10%) lower than Mayo Clinic values.
  • The Mayo Clinic equation yielded a mean eGFR difference of 7.2 ml/min/1.73 m² (15%) between laboratories.
  • Agreement within 10% was observed in 36% of results, while 13% showed discordance exceeding 30%.

Conclusions:

  • Significant interlaboratory variability in CysC measurements exists, even with identical assays and manufacturers.
  • This variability leads to clinically relevant differences in eGFR, impacting patient assessment.
  • Awareness of interlaboratory CysC and eGFR variability is crucial for accurate interpretation and comparison of results.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Clearance01:23

Renal Clearance

The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Glomerular Filtration Rate and its Regulation01:28

Glomerular Filtration Rate and its Regulation

The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...